CVS projects full-year guidance to include revenue of at least $382.6 billion and adjusted earnings per share of $6 to $6.20. The company offers a strong dividend yield of 4.5%, making it an appealing ...

Net income from continuing operations (GAAP) remained flat year-over-year at $8.5 million in Q2 2025, despite strong growth in other metrics. These 10 stocks could mint the next wave of millionaires › ...

Hundreds of pharmacies across Pennsylvania have gone out of business in recent years, data obtained by Spotlight PA shows, ...

If you’ve followed health insurance earnings lately, you might be experiencing some whiplash. But some lessons about the ...

They comprise 2.4% of the broader U.S. Market Index, yet are up 10.7% year-to-date. Compare that to technology stocks, which ...

Exxon Mobil’s profit dropped in the second quarter to the lowest level in four years as oil prices declined amid an increase ...

Eli Lilly › Great businesses have a habit of remaining so even when market volatility arises. The stock market is cyclical, ...

Eli Lilly is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Learn more on LLY stock here.

Stocks capped a choppy day of trading on Wall Street with more losses Thursday after an early Big Tech rally faded and a ...

CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.

UnitedHealth Group named Bain Capital executive Wayne DeVeydt as its next CFO, replacing John Rex, who will become strategic advisor to the CEO. The medical products maker raised its earnings outlook ...

Big rallies for Microsoft and Facebook’s parent company are helping lead stocks back toward more record highs.